You are here

Precede Biosciences


Rehan Verjee

Co-founder and CEO, Precede Biosciences

Rehan Verjee is a co-founder and the CEO of Precede Biosciences, a next generation liquid biopsy diagnostic and data sciences company. Previously, Rehan served as President of EMD Serono and as the Global Head of the Innovative Medicine Franchises for Merck KGaA. In this role, he served as a member of the executive committee leading the biopharmaceutical business across the U.S. and Canada in addition to leading the oncology, neurology, and immunology specialty medicine franchises. Prior to this, he served as Executive Vice President, Chief Marketing and Strategy Officer, leading the specialty franchises in addition to business development, market access, portfolio management, and the medical device and services unit.

Verjee is currently a member of the board of directors of Tyra Biosciences and the Massachusetts Biotechnology Council. He holds a master’s degree in Molecular and Cellular Biochemistry from the University of Oxford in the U.K.

Precede Biosciences

Precede Biosciences is a next generation liquid biopsy diagnostic and data sciences company.